Autologous activated macrophages (MAK™) coatedex vivowith humanized anti-CD20 monoclonal antibodies can eradicate minimal residual disease in chronic lymphocytic leukaemia in clinical response-Reference-Cited by-同舟云学术

Autologous activated macrophages (MAK™) coatedex vivowith humanized anti-CD20 monoclonal antibodies can eradicate minimal residual disease in chronic lymphocytic leukaemia in clinical response

Published:2008-09 Issue:6 Volume:142 Page:996-998
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Sutton Laurent,Chaoui Driss,Cazin Bruno,Azar Nabih,Chokri Mohamed,Romet-Lemonne Jean-Loup,Maloum Karim

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07272.x/fullpdf

Reference10 articles.

1. Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level;Brugiatelli;British Journal of Haematology,1997

2. Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma;Chaperot;Leukemia,2000

3. Rituximab consolidation and maintenance immunotherapy improve outcome in B-cell chronic lymphocytic leukemia;Del Poeta;Blood,2007

4. Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects;Faradji;Cancer Immunology Immunotherapy,1991

5. Rituximab plus GM-CSF for patients with chronic lymphocytic leukemia;Ferrajoli;Blood,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation;Neuro-Oncology;2011-10-20

2. Triggering Microglia Oncotoxicity: A Bench Utopia or a Therapeutic Approach?;Tumors of the Central Nervous System, Volume 4;2011-08-08